Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Respir Physiol Neurobiol. 2013 Jun 6;188(2):229–230. doi: 10.1016/j.resp.2013.05.029

Fate of intracellular H2S/HS and metallo-proteins

Philippe Haouzi 1,*, Candice M Klingerman 1
PMCID: PMC3779601  NIHMSID: NIHMS510539  PMID: 23748103

Kenneth Olson has recently developed a theoretical model to predict how endogenously-generated intracellular molecules of H2S would diffuse within and outside the cells (Olson, 2013). Clarifying this question is of major interest since intracellular H2S, which is mostly present under the form of its sulfhydric anion HS, has been hypothesized to be an important actor involved in the transduction of the response to hypoxia (Olson, 2011a).

One of the major implications of Olson’s model, which suggests little, if any, diffusion outside the cytoplasm of endogenously-generated H2S, is that studies supporting a physiological role for this gas, based on its determination in the extracellular milieu -blood for in-vivo experiments or “bath” for tissular or cellular preparations- should be considered with a high degree of skepticism. This notion corroborates results from previous studies (Furne et al., 2008; Whitfield et al., 2008) wherein major methodological pitfalls preventing accurate determination of H2S/HS in the extracellular milieu were identified, accounting for the unrealistic high (microM) baseline levels of sulfide in the blood and in tissues reported in the literature. Although attempts are being made to measure/visualize intracellular H2S/HS (Lin et al., 2013), theoretical models, such as the one proposed by Olson (Olson, 2013), represent an essential step in the development of a rational frame of reference aimed at predicting the fate of endogenous – or exogenous- H2S.

Prediction of the changes in sulfide concentrations remains difficult: the amount, the rate, the site as well as the mechanisms of regulation of the “production” of H2S are far from being established or understood, while the “oxidative” properties of the mitochondria for this gas varies from tissue to tissue and possibly from cell to cell. H2S is also a very reactive molecule. In the reducing milieu of the cytoplasm, sulfhydration of cysteine residues (Mustafa et al., 2009) may be limited, but the interactions of H2S with metallo-proteins are certainly quantitatively significant and pertinent to include into any prediction model. It is H2S reactivity with metal compounds, i.e. ferric iron (methemoglobin) (Haouzi et al., 2011a; Smith and Gosselin, 1966; Van de Louw and Haouzi, 2012) or oxidized cobalt (hydroxocobalamin) (Smith, 1969; Truong et al., 2007; Van de Louw and Haouzi, 2012), which has been offered as a rationale for developing antidotes against H2S poisoning. Similarly, Zn compounds have been used to decrease H2S in the colon (Suarez et al., 1998).

Intra-cytoplasmic and intra-mitochondrial metallo-proteins are as abundant (Dupont et al., 2006) as they are diverse (Karlin, 1993); actually, a large proportion of the pool of proteins present in a cell does contain metal compounds including Fe, Zn, Cu or Co at various levels of oxidation (Waldron et al., 2009). These molecules constitute a large sink in the mitochondria and the cytoplasm for the nM or pM concentrations of H2S produced in a cell. As a result, prediction of the kinetics or the changes in the amplitude of intracellular soluble H2S may prove to be quite challenging.

In addition to this “trapping effect”, enhanced, reduced or even novel functions of metallo-proteins may emerge from the presence of metallo-sulfide. The long list of intracellular metallo-proteins potentially involved in the systemic response to hypoxia includes molecules ranging from myoglobin to some of the most fundamental components of the electron chain, from superoxide dismutase (Searcy et al., 1995) to carbonic anhydrase, and from angiotensin-converting enzyme (Laggner et al., 2007) to various heme proteins. It is, after all, through the combination of H2S/HS with the cytochrome C oxidase that the dreadful toxicity of H2S seems to operate (Dorman et al., 2002).

Incorporating all relevant factors potentially interacting with H2S in a cell is a real challenge, but the development of theoretical models providing realistic anticipation of the fate of H2S must be pursued to clarify the physiological effects of endogenous sulfide -if any- and, as cautioned by Olson, to separate hype from hope (Olson, 2011b).

Acknowledgments

This work was supported by the CounterACT Program, National Institutes of Health Office of the Director (NIH OD), and the National Institute of Neurological Disorders and Stroke (NINDS), Grant Number 1R21NS080788-01.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Dorman DC, Dautrebande L, Moulin FJ, McManus BE, Mahle KC, James RA, Struve MF. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci. 2002;65:18–25. doi: 10.1093/toxsci/65.1.18. [DOI] [PubMed] [Google Scholar]
  2. Dupont CL, Yang S, Palenik B, Bourne PE. Modern proteomes contain putative imprints of ancient shifts in trace metal geochemistry. Proc Natl Acad Sci U S A. 2006;103:17822–17827. doi: 10.1073/pnas.0605798103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Furne J, Saeed A, Levitt MD. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1479–1485. doi: 10.1152/ajpregu.90566.2008. [DOI] [PubMed] [Google Scholar]
  4. Haouzi P, Bell H, Philmon M. Hydrogen sulfide oxidation and the arterial chemoreflex: Effect of methemoglobin. Respir Physiol Neurobiol. 2011a;177:273–283. doi: 10.1016/j.resp.2011.04.025. [DOI] [PubMed] [Google Scholar]
  5. Karlin KD. Metalloenzymes, structural motifs, and inorganic models. Science. 1993;261:701–708. doi: 10.1126/science.7688141. [DOI] [PubMed] [Google Scholar]
  6. Laggner H, Hermann M, Esterbauer H, Muellner MK, Exner M, Gmeiner BM, Kapiotis S. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens. 2007;25:2100–2104. doi: 10.1097/HJH.0b013e32829b8fd0. [DOI] [PubMed] [Google Scholar]
  7. Lin VS, Lippert AR, Chang CJ. Cell-trappable fluorescent probes for endogenous hydrogen sulfide signaling and imaging H2O2-dependent H2S production. Proc Natl Acad Sci U S A. 2013;110:7131–7135. doi: 10.1073/pnas.1302193110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, Snyder SH. H2S signals through protein S-sulfhydration. Sci Signal. 2009;2:ra72. doi: 10.1126/scisignal.2000464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Olson KR. Hydrogen sulfide is an oxygen sensor in the carotid body. Respir Physiol Neurobiol. 2011a;179:103–110. doi: 10.1016/j.resp.2011.09.010. [DOI] [PubMed] [Google Scholar]
  10. Olson KR. The therapeutic potential of hydrogen sulfide: separating hype from hope. Am J Physiol Regul Integr Comp Physiol. 2011b;301:R297–312. doi: 10.1152/ajpregu.00045.2011. [DOI] [PubMed] [Google Scholar]
  11. Olson KR. A theoretical examination of hydrogen sulfide metabolism and its potential in autocrine/paracrine oxygen sensing. Respir Physiol Neurobiol. 2013;186:173–179. doi: 10.1016/j.resp.2013.01.010. [DOI] [PubMed] [Google Scholar]
  12. Searcy DG, Whitehead JP, Maroney MJ. Interaction of Cu,Zn superoxide dismutase with hydrogen sulfide. Arch Biochem Biophys. 1995;318:251–263. doi: 10.1006/abbi.1995.1228. [DOI] [PubMed] [Google Scholar]
  13. Smith RP. Cobalt salts: effects in cyanide and sulfide poisoning and on methemoglobinemia. Toxicol Appl Pharmacol. 1969;15:505–516. doi: 10.1016/0041-008x(69)90052-0. [DOI] [PubMed] [Google Scholar]
  14. Smith RP, Gosselin RE. On the mechanism of sulfide inactivation by methemoglobin. Toxicol Appl Pharmacol. 1966;8:159–172. doi: 10.1016/0041-008x(66)90112-8. [DOI] [PubMed] [Google Scholar]
  15. Suarez F, Furne J, Springfield J, Levitt M. Production and elimination of sulfur-containing gases in the rat colon. Am J Physiol. 1998;274:G727–733. doi: 10.1152/ajpgi.1998.274.4.G727. [DOI] [PubMed] [Google Scholar]
  16. Truong DH, Mihajlovic A, Gunness P, Hindmarsh W, O’Brien PJ. Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B(12a)) Toxicology. 2007;242:16–22. doi: 10.1016/j.tox.2007.09.009. [DOI] [PubMed] [Google Scholar]
  17. Van de Louw A, Haouzi P. Ferric Iron and Cobalt (III) Compounds to Safely Decrease Hydrogen Sulfide in the Body? Antioxid Redox Signal. 2012 doi: 10.1089/ars.2012.4513. [DOI] [PubMed] [Google Scholar]
  18. Waldron KJ, Rutherford JC, Ford D, Robinson NJ. Metalloproteins and metal sensing. Nature. 2009;460:823–830. doi: 10.1038/nature08300. [DOI] [PubMed] [Google Scholar]
  19. Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR. Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1930–1937. doi: 10.1152/ajpregu.00025.2008. [DOI] [PubMed] [Google Scholar]

RESOURCES